Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.21)
# 1871
Out of 5,368 analysts
209
Total ratings
52.86%
Success rate
-4.09%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IRTC iRhythm Technologies | Maintains: Overweight | 130 160 | 143.89 | 11.2% | 16 | Jun 11, 2025 | |
ZBH Zimmer Biomet Holdin... | Maintains: Equal-Weight | 115 95 | 91.28 | 4.08% | 12 | May 6, 2025 | |
NVRO Nevro | Downgrades: Underweight | 9 4 | n/a | n/a | 9 | Dec 2, 2024 | |
ISRG Intuitive Surgical | Upgrades: Overweight | 522 650 | 511.75 | 27.02% | 13 | Dec 2, 2024 | |
SGHT Sight Sciences | Maintains: Equal-Weight | 7 5 | 4.14 | 20.77% | 15 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 13 12 | 9.56 | 25.52% | 12 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 95 | 142.92 | -33.53% | 12 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 104 98 | 87.22 | 12.36% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 76 69 | n/a | n/a | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 83 83 | n/a | n/a | 10 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 1 | n/a | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 78 85 | 86.19 | -1.38% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 224 291 | n/a | n/a | 6 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 15 | 28.24 | -46.88% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 325 343 | 304.5 | 12.64% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 14 | 3.04 | 360.53% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 44 48 | 30.6 | 56.86% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 102 | 75.15 | 35.73% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 56 58 | 99.69 | -41.82% | 16 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 20 | 12.34 | 62.07% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 117 131 | 81.92 | 59.91% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 135.57 | -1.9% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 235 380 | n/a | n/a | 2 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 270 220 | 377.25 | -41.68% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 383 378 | 119.94 | 215.16% | 2 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 29 25 | n/a | n/a | 3 | Jan 7, 2022 |